Large Cap High Growth Potential
Results
5
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €773.80 | -1.3% | 64.3% | €47.4b | €849.01 | 37.0 | 21.7% | n/a | Pharmaceuticals & Biotech | ||
ELI | €132.30 | -2.6% | 39.6% | €14.4b | €148.37 | 25.9 | 14.6% | 1.5% | Utilities | ||
GBLB | €79.20 | -1.5% | 11.7% | €9.8b | €89.01 | 1.5 | 70.7% | 6.5% | Diversified Financials | ||
UCB | €249.70 | -9.2% | 58.5% | €47.4b | €292.44 | 30.5 | 17.9% | 0.6% | Pharmaceuticals & Biotech | ||
LOTB | €11,180.00 | -4.4% | 33.1% | €9.1b | €11,129.30 | 52.7 | 10.6% | 0.8% | Food, Beverage & Tobacco |
Page 1 of 1
